This site is intended for healthcare professionals only
This webcast series and supporting materials was developed by the Chronic Conditions faculty in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the agenda, speaker selection, presentations or collateral content, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.

Chronic Conditions Month 2022

Renal

On-demand videos

Putting the new NICE guidance into practice: ‘An update on the management of chronic kidney disease in primary care’
Part 1

These video presentations were originally broadcast on the 18 May 2022.

Pleae note that the speakers are not able to answer questions from attendees watching the video on-demand

Putting the new NICE guidance into practice: ‘An update on the management of chronic kidney disease in primary care’
Part 2

These video presentations were originally broadcast on the 18 May 2022.

Pleae note that the speakers are not able to answer questions from attendees watching the video on-demand

Chronic Conditions Month 2022

Renal

Join us for a series of interactive webinars and podcasts to help you optimise care for people with chronic conditions

The agenda

13:00-13:45

Putting the new NICE guidance into practice: ‘An update on the management of chronic kidney disease in primary care’

  • Classification of CKD
  • Interpretation of eGFR & urinary ACR and pitfalls to avoid
  • Delaying the progression of CKD Part 1: Using well established risk factor management

13:45-14:20

A New Era in the Management of Cardio-Renal Risk: Bringing Protection to Life

This is a promotional symposium sponsored and organised by AstraZeneca

Professor David Wheeler

Professor of Nephrology, University College London

Professor Martin Cowie

Professor of Cardiology, Royal Brompton Hospital

14:20-15:00

Putting the new NICE guidance into practice: ‘An update on the management of chronic kidney disease in primary care’

  • Delaying the progression of CKD Part 2: SGLT2i and what does NICE recommend
  • Managing anaemia in CKD
  • When to refer

The speakers

Patrick Holmes

GP, Darlington

Steve Holmes

GP, Shepton Mallet and Clinical Respiratory Lead, NHS England South West and NHS Somerset

Therapy webcast sponsor

Astrazeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas- Oncology, Cardiovascular, Renal & Metabolism and Respiratory. 

AstraZeneca has provided a sponsorship grant towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, except for the AstraZeneca sponsored symposia presentations.
chronic-conditions-logo-white
© Copyright Omniamed Communications. All Rights Reserved 108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom